Published online before print January 15, 2004, doi: 10.1161/01.ATV.0000117200.46938.e7
© 2004 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Telomere Shortening in Human Coronary Artery Diseases
From the Departments of Pathology (M. Ogami, Y.I., M. Ohsawa, T.M., S.K., N.Y., E.H., N.S., M.U.) and Internal Medicine and Cardiology (S.E.), Osaka City University Graduate School of Medicine, Osaka, Japan; and the Department of Cardiology (R.K., T.N.), Osaka City General Hospital, Osaka, Japan.
Correspondence to Dr Yoshihiro Ikura, Department of Pathology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. E-mail ikura{at}med.osaka-cu.ac.jp
Background— Increased cell turnover in response to injury is considered to be important in the development of atherosclerotic plaques. Telomere shortening has been shown to be associated with cell turnover. We assessed the telomere length of human coronary endothelial cells to clarify whether there is a relationship between telomere shortening and coronary artery disease (CAD).
Methods and Results— Coronary endothelial cells were obtained from 11 patients with CAD who underwent autopsy and 22 patients without CAD who underwent autopsy by scraping off the luminal surface of coronary arteries. DNA extracted from the endothelial cells were blotted and hybridized with telomere-specific oligonucleotide ([TTAGGG]4). The hybridization signal intensity, which represented telomeric DNA content, was standardized with centromeric DNA content (T/C ratio) to estimate telomere length. The T/C ratios were significantly smaller (P<0.0001) in CAD patients than in age-matched non-CAD patients (CAD patients, 0.462±0.135; non-CAD patients, 1.002±0.212). In 6 individual CAD patients, the T/C ratio at the atherosclerotic lesion was significantly smaller (P<0.05) than that at the non-atherosclerotic portion.
Conclusions— These findings suggest that focal replicative senescence and telomere shortening of endothelial cells may play a critical role in coronary atherogenesis and CAD.
Key Words: telomere • senescence • endothelial cells • coronary artery disease
This article has been cited by other articles:
 |
|
 |
|
  T. De Meyer, E. R. Rietzschel, M. L. De Buyzere, M. R. Langlois, D. De Bacquer, P. Segers, P. Van Damme, G. G. De Backer, P. Van Oostveldt, W. Van Criekinge, et al. Systemic telomere length and preclinical atherosclerosis: the Asklepios Study Eur. Heart J., August 17, 2009; (2009) ehp324v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chobotova Aging and Cancer: Converging Routes to Disease Prevention Integr Cancer Ther, June 1, 2009; 8(2): 115 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 M Mukherjee, S Brouilette, S Stevens, K R Shetty, and N J Samani Association of shorter telomeres with coronary artery disease in Indian subjects Heart, April 1, 2009; 95(8): 669 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, X. Huang, H. Jiang, Y. Zhang, H. Liu, C. Qin, G. M. Eisner, P. Jose, L. Rudolph, and Z. Ju Short Telomeres and Prognosis of Hypertension in a Chinese Population Hypertension, April 1, 2009; 53(4): 639 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Erusalimsky and C. Skene Mechanisms of endothelial senescence Exp Physiol, March 1, 2009; 94(3): 299 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing Cardiovasc Res, February 1, 2009; 81(2): 244 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Erusalimsky Vascular endothelial senescence: from mechanisms to pathophysiology J Appl Physiol, January 1, 2009; 106(1): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. MacNee, J. Maclay, and D. McAllister Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S.M. Wong, R. A. de Boer, N. J. Samani, D. J. van Veldhuisen, and P. van der Harst Telomere biology in heart failure Eur J Heart Fail, November 1, 2008; 10(11): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Z. Guan, T. Maeda, M. Sugano, J.-i. Oyama, Y. Higuchi, T. Suzuki, and N. Makino A Percentage Analysis of the Telomere Length in Parkinson's Disease Patients J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J Samani and P. van der Harst Biological ageing and cardiovascular disease Heart, May 1, 2008; 94(5): 537 - 539. [Full Text] [PDF]
|
|
|
|
|
|
S W Brouilette, A Whittaker, S E Stevens, P van der Harst, A H Goodall, and N J Samani Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis Heart, April 1, 2008; 94(4): 422 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Herbert, Y. Mistry, R. Hastings, T. Poolman, L. Niklason, and B. Williams Angiotensin II-Mediated Oxidative DNA Damage Accelerates Cellular Senescence in Cultured Human Vascular Smooth Muscle Cells via Telomere-Dependent and Independent Pathways Circ. Res., February 1, 2008; 102(2): 201 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Reilly, E. J. Westgate, and G. A. FitzGerald Peripheral Circadian Clocks in the Vasculature Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1694 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Shi, G. B. Hubbard, R. S. Kushwaha, D. Rainwater, C. A. Thomas III, M. M. Leland, J. L. VandeBerg, and X. L. Wang Endothelial senescence after high-cholesterol, high-fat diet challenge in baboons Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2913 - H2920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. van der Harst, G. van der Steege, R. A. de Boer, A. A. Voors, A. S. Hall, M. J. Mulder, W. H. van Gilst, D. J. van Veldhuisen, and on behalf of the MERIT-HF Study Group Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1459 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minamino and I. Komuro Vascular Cell Senescence: Contribution to Atherosclerosis Circ. Res., January 5, 2007; 100(1): 15 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kunieda, T. Minamino, J.-i. Nishi, K. Tateno, T. Oyama, T. Katsuno, H. Miyauchi, M. Orimo, S. Okada, M. Takamura, et al. Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway Circulation, August 29, 2006; 114(9): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Matthews, I. Gorenne, S. Scott, N. Figg, P. Kirkpatrick, A. Ritchie, M. Goddard, and M. Bennett Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress Circ. Res., July 21, 2006; 99(2): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kunieda, T. Minamino, T. Katsuno, K. Tateno, J.-i. Nishi, H. Miyauchi, M. Orimo, S. Okada, and I. Komuro Cellular Senescence Impairs Circadian Expression of Clock Genes In Vitro and In Vivo Circ. Res., March 3, 2006; 98(4): 532 - 539. [Abstract] [Full Text] [PDF]
|
|